Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

Research Institute of the McGill University Health Centre

$719,566.00

Genomics of mycobacterial pathogenesis

FY 2008-09

Summary
The availability of genome sequence data has permitted a renewed approach to understanding how certain bacteria cause disease. This has been particularly valuable in understanding the bacteria that causes tuberculosis, called Mycobacterium tuberculosis, and the closely related bacteria used as a vaccine against tuberculosis, called BCG. In this project, we plan to continuing studying mycobacterial pathogens, using a variety of genomic methods. Previously, these organisms were characterized by their loss of DNA, but studies by our group and others have shown that these organisms are also able to gain new genetic elements. The goal of our research is to understand how the acquisition of new genes by these organisms mediates virulence, which is their capacity to cause disease. The ultimate goal is to have a better understanding of the basis of disease, towards the development of improved diagnostic tests and vaccines.
Program
Operating Grant
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
179106
Name
Behr Marcel A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Genomics of mycobacterial pathogenesis
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$719,566
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Gene Deletion; Genomics; Microarrays; Mycobacterial Pathogenesis; Transcriptome; Virulence
Abstract
The availability of genome sequence data has permitted a renewed approach to understanding how certain bacteria cause disease. This has been particularly valuable in understanding the bacteria that causes tuberculosis, called Mycobacterium tuberculosis, and the closely related bacteria used as a vaccine against tuberculosis, called BCG. In this project, we plan to continuing studying mycobacterial pathogens, using a variety of genomic methods. Previously, these organisms were characterized by their loss of DNA, but studies by our group and others have shown that these organisms are also able to gain new genetic elements. The goal of our research is to understand how the acquisition of new genes by these organisms mediates virulence, which is their capacity to cause disease. The ultimate goal is to have a better understanding of the basis of disease, towards the development of improved diagnostic tests and vaccines.
Competitiondate
200903
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Behr, Marcel A
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $719,566~ $0~
Research Institute of the McGill University Health Ce… | Canada Spends